Abstract: An electrochemical device and an electronic device. The electrochemical device includes a positive electrode plate, a negative electrode plate, an electrolyte solution, and a separator. A mass percent A of the electrolyte solution in a total mass of a battery cell is 2% to 8%. The electrolyte solution includes a sulfur-containing substance with a valence of S4+/S6+ or above. Based on a total mass of the electrolyte solution, a mass percent B of the sulfur-containing substance is 10% to 20%. By controlling the mass percent of the electrolyte solution and the use of the sulfur-containing substance and the fluorine-containing additive, the ionic conductivity of the SEI film is improved, and consumption of the electrolyte solution during cycling is reduced, thereby enhancing safety performance and cycle performance while reducing the electrolyte volume.

Abstract: A fast calibration test system and method for a phased-array antenna, which belongs to the technical field of antenna measurement, relates to a near-field test system, and relates in particular to the fast calibration and a directional diagram test on a phased-array antenna.

Abstract: The invention includes methods of preventing or treating acute lung injury using a MAP3K2/MAP3K3 inhibitor. The invention further comprises compositions, and kits comprising compositions useful within the invention.

Abstract: The invention includes methods of preventing or treating acute lung injury using a MAP3K2/MAP3K3 inhibitor. The invention further comprises compositions, and kits comprising compositions useful within the invention.

Abstract: The disclosure includes methods of preventing, ameliorating, and/or treating ischemia-reperfusion injury (IRI), including but not limited to post brain stroke, using a MAP3K2/MAP3K3 inhibitor. In another aspect, the present disclosure relates to methods of preventing, ameliorating, and/or treating a lung injury related to a coronavirus infection, acute lung injury (ALI) and/or acute respiratory distress syndrome (ARDS) using a MAP3K2/MAP3K3 inhibitor. The disclosure further comprises compositions, and kits comprising compositions useful within the disclosure.

Abstract: A processing system includes physical function circuitry to execute virtual functions and a processing unit configured to operate in a first mode that allows more than one virtual function to execute on the physical function circuitry and a second mode that constrains the physical function circuitry to executing a single virtual function. A first virtual function modifies a state of the processing unit in response to the processing unit being in the second mode. A host driver executing on the processing unit modifies an operating mode indicator to indicate that the processing unit is operating in the first mode or to indicate that the processing unit is operating in the second mode. Microcode executing on the processing unit accesses the operating mode indicator to determine whether the processing unit is operating in the first mode or the second mode.

Abstract: The invention includes methods of preventing or treating acute lung injury using a MAP3K2/MAP3K3 inhibitor. The invention further comprises compositions, and kits comprising compositions useful within the invention.

Abstract: The invention includes methods of preventing or treating acute lung injury using a MAP3K2/MAP3K3 inhibitor. The invention further comprises compositions, and kits comprising compositions useful within the invention.

Abstract: The invention includes methods of preventing or treating acute lung injury using a MAP3K2/MAP3K3 inhibitor. The invention further comprises compositions, and kits comprising compositions useful within the invention.